OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Enhancing these processes involves modifying various variables, including cell line engineering, media formulation, and bioreactor settings. A key goal is to maximize antibody production while reducing production costs